Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
about
Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood testUlcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapseDisease monitoring in inflammatory bowel diseaseFecal DNA testing for colorectal cancer screening: Molecular targets and perspectivesCohort Profile: The Taiwan MJ Cohort: half a million Chinese with repeated health surveillance data.Colorectal cancer: from prevention to personalized medicine.Advances in Fecal Occult Blood Tests: the FIT revolution.As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasiaThe Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test--A Rapid Office Based Assay Test for the Detection of Colorectal Cancer.Results of faecal immunochemical test for colorectal cancer screening, in average risk population, in a cohort of 1389 subjectsComparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk populationSensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.Fecal immunochemical test for colorectal cancer from a prospective cohort with 513,283 individuals: Providing detailed number needed to scope (NNS) before colonoscopy.Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial.Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme.Evaluation of fecal immunochemical tests for colorectal cancer screeningPopulation-based colorectal cancer screening: comparison of two fecal occult blood testAssessment of disease activity by fecal immunochemical test in ulcerative colitis.Fecal immunochemical test accuracy in average-risk colorectal cancer screening.Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs.Cancer screening in people who have chronic disease: the example of kidney disease.Screening for colorectal cancer: established and emerging modalities.Colorectal cancer screening--optimizing current strategies and new directions.Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy.Opportunistic screening for colorectal neoplasia in Singapore using faecal immunochemical occult blood test.Ambient temperature and FIT performance in the Emilia-Romagna colorectal cancer screening programme.Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin.Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening.Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study.Fecal immunochemical test accuracy in familial risk colorectal cancer screening.Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients.Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.Effect of sample storage temperature and buffer formulation on faecal immunochemical test haemoglobin measurements.
P2860
Q24630835-C359ED7D-278D-45DA-B3DC-6A5A01279D06Q24658603-6B527030-9E86-4871-9B74-7D4F8C545B60Q26777553-A805A560-15B1-402E-B1C6-34764F8734D7Q26781466-5AB26323-D3FC-414F-B2DA-55B5CD52F136Q31162374-3976F93C-4118-4BFD-AFAF-5053EB1DBD68Q33735234-F5B6AFA8-DCDD-4248-BA64-4976D7802DB4Q34666990-04692D98-9547-4823-B309-A2C0442A9B44Q35206019-E7783132-16D6-4F73-B1ED-809DA6FE0025Q35687171-CD731C5B-2665-46B9-8CF7-38C2E536D2AAQ35713849-A6172110-3658-4030-A039-0C1081E6667EQ35761319-BBF2D786-3D33-4129-A91F-82613739BC68Q36609425-846A1998-471F-4D83-960B-3E244D30D9E8Q36609690-80147472-0AE6-4794-9986-7FFF28BF28C6Q37081068-F2410913-D95D-4880-AC17-BF68684CC675Q37160688-8809FDDC-CDA8-4647-BF9C-3F5CA4C10AC5Q37256812-BDEE9447-E272-4353-B5D1-339E66CE5C45Q37381774-DA4BC6B8-E2B5-4135-9463-D96A950F7BDCQ37401522-25602A38-9B89-42C3-B00C-BB4F7D93E656Q37429097-8109241A-376C-4246-9AFA-0EE2493FF2D4Q37459521-F5217C7D-6B9F-40D7-9AC6-D398B22E4EF4Q37538938-80B5554E-BD18-4DC5-AD45-6DFE01AEF019Q37578685-CB146E25-F5E7-486C-A0A1-8FB8FB2F7192Q37698569-61AAC136-AB05-4D68-9FC5-CF78E058D8CAQ37845426-52800F76-ED59-4138-BFE0-CE2168F5784BQ37951776-5F443867-7B96-4CE1-A56A-54FA59F96862Q38079126-E3AA954E-6E4A-4624-B5D5-C7624A253FB9Q38515202-EBF7005F-E2AB-4782-BBAB-48C2BBC5CFC5Q38962467-50FBCD00-C47E-4F57-9418-86D1367E789CQ39428895-0E027A1D-56DC-4B92-AA84-A062505A7ED0Q39812975-DB9FD544-AEB9-4CE0-9BEB-B86CD26850B8Q40353649-36A39CFB-19D9-4D3D-82FE-B775F1A04662Q44981714-FCD8E05E-1E07-46DF-A222-D073FA919E8FQ45389254-6EDC4770-A21E-43E2-A7E9-D7B40C2B7322Q46005311-A5D23D2B-42EC-433E-8264-216B41775F67Q46100311-C6C352F4-76E6-474A-B651-8FACE3AD2461Q46569204-788E187B-A7D4-492B-B474-564A4011C590Q50864490-D98223EE-BEEA-4A25-A2B2-A7D8FC81B3F0Q50958798-572A3F76-5A99-4D3B-B7F5-859D4E6BE929Q50966522-8B45924E-FFE2-4B6E-9436-229CF64BE000Q53125362-C60F97E2-F8A0-488A-B681-191BF2C241F8
P2860
Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Performance characteristics an ...... l occult blood screening test.
@en
Performance characteristics an ...... l occult blood screening test.
@nl
type
label
Performance characteristics an ...... l occult blood screening test.
@en
Performance characteristics an ...... l occult blood screening test.
@nl
prefLabel
Performance characteristics an ...... l occult blood screening test.
@en
Performance characteristics an ...... l occult blood screening test.
@nl
P2093
P2860
P1476
Performance characteristics an ...... l occult blood screening test.
@en
P2093
Alex Vilkin
Amal Waked
Paul Rozen
Shlomo Birkenfeld
P2860
P304
P356
10.1111/J.1572-0241.2005.00231.X
P407
P50
P577
2005-11-01T00:00:00Z